No abstract available
Publication types
-
Clinical Trial, Phase I
-
Letter
MeSH terms
-
Adult
-
Antineoplastic Agents / therapeutic use*
-
Cyclin-Dependent Kinases / antagonists & inhibitors*
-
Disease Progression
-
Humans
-
Male
-
Neoplasms, Germ Cell and Embryonal / drug therapy*
-
Neoplasms, Germ Cell and Embryonal / pathology
-
Neoplasms, Second Primary / drug therapy*
-
Neoplasms, Second Primary / metabolism
-
Piperazines / therapeutic use*
-
Pyridines / therapeutic use*
-
Retinoblastoma Protein / metabolism
-
Teratoma / drug therapy*
-
Teratoma / metabolism
-
Young Adult
Substances
-
Antineoplastic Agents
-
Piperazines
-
Pyridines
-
Retinoblastoma Protein
-
Cyclin-Dependent Kinases
-
palbociclib
Associated data
-
ClinicalTrials.gov/NCT00141297